BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 17950331)

  • 1. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
    Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
    J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
    Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
    Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
    Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
    Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis.
    Kollmar O; Scheuer C; Menger MD; Schilling MK
    Ann Surg Oncol; 2006 Feb; 13(2):263-75. PubMed ID: 16424980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    Mi J; Sarraf-Yazdi S; Zhang X; Cao Y; Dewhirst MW; Kontos CD; Li CY; Clary BM
    J Surg Res; 2006 Mar; 131(1):97-104. PubMed ID: 16242720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.
    Yu HK; Ahn JH; Lee HJ; Lee SK; Hong SW; Yoon Y; Kim JS
    J Gene Med; 2005 Jan; 7(1):39-49. PubMed ID: 15517541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
    Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF
    Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
    Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
    Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
    Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
    Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.
    Oliner J; Min H; Leal J; Yu D; Rao S; You E; Tang X; Kim H; Meyer S; Han SJ; Hawkins N; Rosenfeld R; Davy E; Graham K; Jacobsen F; Stevenson S; Ho J; Chen Q; Hartmann T; Michaels M; Kelley M; Li L; Sitney K; Martin F; Sun JR; Zhang N; Lu J; Estrada J; Kumar R; Coxon A; Kaufman S; Pretorius J; Scully S; Cattley R; Payton M; Coats S; Nguyen L; Desilva B; Ndifor A; Hayward I; Radinsky R; Boone T; Kendall R
    Cancer Cell; 2004 Nov; 6(5):507-16. PubMed ID: 15542434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
    Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
    Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
    Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
    Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats].
    Li WZ; Yang P; Peng GC; Tang HH; Zhou J; Fu CY; Feng DY; Zhou X; Huang MP; Zhou GF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):523-7. PubMed ID: 16951510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
    Bandyopadhyay A; Wang L; López-Casillas F; Mendoza V; Yeh IT; Sun L
    Prostate; 2005 Apr; 63(1):81-90. PubMed ID: 15468171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD; Hu Y; Zhang L; Huang J; Sun CY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.